-
1
-
-
0028998983
-
A quality of life perspective on who benefits from estradiol replacement therapy
-
Karlberg J, Mattsson L-Å, Wiklund I. A quality of life perspective on who benefits from estradiol replacement therapy. Acta Obstet Gynecol Scand 1995; 74: 367–372.
-
(1995)
Acta Obstet Gynecol Scand
, vol.74
, pp. 367-372
-
-
Karlberg, J.1
Mattsson, L.-Å.2
Wiklund, I.3
-
2
-
-
0027408428
-
Quality of life of postmeno-pausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study
-
Wiklund I, Karlberg J, Mattsson L-Å. Quality of life of postmeno-pausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168: 824–830.
-
(1993)
Am J Obstet Gynecol
, vol.168
, pp. 824-830
-
-
Wiklund, I.1
Karlberg, J.2
Mattsson, L.-Å.3
-
4
-
-
0018965660
-
Estrogen use in postmenopausal women: Costs, risks, and benefits
-
Weinstein MC. Estrogen use in postmenopausal women: costs, risks, and benefits. N Engl J Med 1980; 303: 308–316.
-
(1980)
N Engl J Med
, vol.303
, pp. 308-316
-
-
Weinstein, M.C.1
-
5
-
-
0021003218
-
Cost-effectiveness of hormone replacement therapy in the menopause
-
Weinstein MC, Schiff I. Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynaecol Surv 1983; 38: 445–455.
-
(1983)
Obstet Gynaecol Surv
, vol.38
, pp. 445-455
-
-
Weinstein, M.C.1
Schiff, I.2
-
6
-
-
0025153446
-
Cost-effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement theory
-
Tosteson A, Rosenthal DI, Melton LJ, Weinstein MC. Cost-effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement theory. Ann Intern Med 1990; 113: 594–603.
-
(1990)
Ann Intern Med
, vol.113
, pp. 594-603
-
-
Tosteson, A.1
Rosenthal, D.I.2
Melton, L.J.3
Weinstein, M.C.4
-
7
-
-
0026600502
-
HRT: An analysis of benefits, risks and costs
-
Daly E, Roche M, Barlow D, Gray A, McPherson K, Vessey M. HRT: an analysis of benefits, risks and costs. Br Med Bull 1992; 48: 368–400.
-
(1992)
Br Med Bull
, vol.48
, pp. 368-400
-
-
Daly, E.1
Roche, M.2
Barlow, D.3
Gray, A.4
McPherson, K.5
Vessey, M.6
-
8
-
-
0026586037
-
A cost-effectiveness analysis of hormone replacement therapy in the menopause
-
Cheung AP, Wren BG. A cost-effectiveness analysis of hormone replacement therapy in the menopause. Med J Aust 1992; 156: 312–316.
-
(1992)
Med J Aust
, vol.156
, pp. 312-316
-
-
Cheung, A.P.1
Wren, B.G.2
-
9
-
-
0027221136
-
Measuring the impact of menopausal symptoms on quality of life
-
Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993; 307: 836–840.
-
(1993)
BMJ
, vol.307
, pp. 836-840
-
-
Daly, E.1
Gray, A.2
Barlow, D.3
McPherson, K.4
Roche, M.5
Vessey, M.6
-
10
-
-
0021703009
-
Preference for health outcomes: Comparison of assessment methods
-
Read, JL, Quinn RJ, Berwick DM, Fineberrg HV, Weinstein MC. Preference for health outcomes: comparison of assessment methods. Med Decis Making 1984; 4: 315–329.
-
(1984)
Med Decis Making
, vol.4
, pp. 315-329
-
-
Read, J.L.1
Quinn, R.J.2
Berwick, D.M.3
Fineberrg, H.V.4
Weinstein, M.C.5
-
11
-
-
0026751659
-
Variability among methods to assess patients’ well-being and consequent effect on a cost-effectiveness analysis
-
Homberger JC, Redelmeier DA, Peterson J. Variability among methods to assess patients’ well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45: 505–512.
-
(1992)
J Clin Epidemiol
, vol.45
, pp. 505-512
-
-
Homberger, J.C.1
Redelmeier, D.A.2
Peterson, J.3
-
12
-
-
0029794708
-
Recommendations of the panel on cost-effectiveness in health and medicine
-
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1253–1258.
-
(1996)
JAMA
, vol.276
, pp. 1253-1258
-
-
Weinstein, M.C.1
Siegel, J.E.2
Gold, M.R.3
Kamlet, M.S.4
Russell, L.B.5
-
13
-
-
85040415589
-
-
SBU- Stockholm SBU
-
The Swedish Council on Technology Assessment in Health Care (SBU). Oestrogen Treatment, SBU-report no. 131. Stockholm: SBU, 1996.
-
(1996)
Oestrogen Treatment
-
-
-
14
-
-
85040386349
-
Kvinnor över 50 allt mer hormoniska. National Corporation of Swedish Pharmacies
-
Östrogen/Gestagen. Kvinnor över 50 allt mer hormoniska. National Corporation of Swedish Pharmacies. IA kontakt 1995; 5: 1–4.
-
(1995)
IA kontakt
, vol.5
, pp. 1-4
-
-
-
15
-
-
0025981829
-
Economic evaluation in health care: Is there a role for cost-benefit analysis
-
Johannesson M, Jonsson B. Economic evaluation in health care: is there a role for cost-benefit analysis Health Policy 1991; 17: 1–23.
-
(1991)
Health Policy
, vol.17
, pp. 1-23
-
-
Johannesson, M.1
Jonsson, B.2
-
17
-
-
0001145903
-
Constructed markets
-
Braden JB, Kolstad CD, editors., Amsterdam, Elsevier/North Holland
-
Carson RT. Constructed markets. In: Braden JB, Kolstad CD, editors. Measuring the Demand for Environmental Quality. Amsterdam: Elsevier/North Holland, 1991.
-
(1991)
Measuring the Demand for Environmental Quality
-
-
Carson, R.T.1
-
18
-
-
0000054750
-
A non-parametric approach to the estimation of welfare measures of discrete response valuation studies
-
Kristrom, B. A non-parametric approach to the estimation of welfare measures of discrete response valuation studies. Land Economics 1990; 66: 135–139.
-
(1990)
Land Economics
, vol.66
, pp. 135-139
-
-
Kristrom, B.1
|